RT Journal Article
SR Electronic
T1 British Society of Gastroenterology consensus guidelines on the management of inflammatory bowel disease in adults
JF Gut
JO Gut
FD BMJ Publishing Group Ltd and British Society of Gastroenterology
SP s1
OP s106
DO 10.1136/gutjnl-2019-318484
VO 68
IS Suppl 3
A1 Christopher Andrew Lamb
A1 Nicholas A Kennedy
A1 Tim Raine
A1 Philip Anthony Hendy
A1 Philip J Smith
A1 Jimmy K Limdi
A1 Bu’Hussain Hayee
A1 Miranda C E Lomer
A1 Gareth C Parkes
A1 Christian Selinger
A1 Kevin J Barrett
A1 R Justin Davies
A1 Cathy Bennett
A1 Stuart Gittens
A1 Malcolm G Dunlop
A1 Omar Faiz
A1 Aileen Fraser
A1 Vikki Garrick
A1 Paul D Johnston
A1 Miles Parkes
A1 Jeremy Sanderson
A1 Helen Terry
A1 IBD guidelines eDelphi consensus group
A1 Daniel R Gaya
A1 Tariq H Iqbal
A1 Stuart A Taylor
A1 Melissa Smith
A1 Matthew Brookes
A1 Richard Hansen
A1 A Barney Hawthorne
YR 2019
UL http://gut.bmj.com/content/68/Suppl_3/s1.abstract
AB Ulcerative colitis and Crohn’s disease are the principal forms of inflammatory bowel disease. Both represent chronic inflammation of the gastrointestinal tract, which displays heterogeneity in inflammatory and symptomatic burden between patients and within individuals over time. Optimal management relies on understanding and tailoring evidence-based interventions by clinicians in partnership with patients. This guideline for management of inflammatory bowel disease in adults over 16 years of age was developed by Stakeholders representing UK physicians (British Society of Gastroenterology), surgeons (Association of Coloproctology of Great Britain and Ireland), specialist nurses (Royal College of Nursing), paediatricians (British Society of Paediatric Gastroenterology, Hepatology and Nutrition), dietitians (British Dietetic Association), radiologists (British Society of Gastrointestinal and Abdominal Radiology), general practitioners (Primary Care Society for Gastroenterology) and patients (Crohn’s and Colitis UK). A systematic review of 88 247 publications and a Delphi consensus process involving 81 multidisciplinary clinicians and patients was undertaken to develop 168 evidence- and expert opinion-based recommendations for pharmacological, non-pharmacological and surgical interventions, as well as optimal service delivery in the management of both ulcerative colitis and Crohn’s disease. Comprehensive up-to-date guidance is provided regarding indications for, initiation and monitoring of immunosuppressive therapies, nutrition interventions, pre-, peri- and postoperative management, as well as structure and function of the multidisciplinary team and integration between primary and secondary care. Twenty research priorities to inform future clinical management are presented, alongside objective measurement of priority importance, determined by 2379 electronic survey responses from individuals living with ulcerative colitis and Crohn’s disease, including patients, their families and friends.